These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21979217)

  • 1. Splenic littoral cell hemangioendothelioma in a patient with Crohn's disease previously treated with immunomodulators and anti-TNF agents: a rare tumor linked to deep immunosuppression.
    Cappello M; Bravatà I; Cocorullo G; Cacciatore M; Florena AM
    Am J Gastroenterol; 2011 Oct; 106(10):1863-5. PubMed ID: 21979217
    [No Abstract]   [Full Text] [Related]  

  • 2. How to improve the safety of biologic therapy in Crohn's disease.
    Ferkolj I
    J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():67-70. PubMed ID: 20388947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
    Dahhan T; Al Kahtani K; Bakshi N; Abouzied ME; Helmy A
    Trop Gastroenterol; 2010; 31(1):51-3. PubMed ID: 20860231
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatosplenic T-cell lymphoma in a 47-year-old Crohn's disease patient on thiopurine monotherapy.
    van de Meeberg MM; Derikx LA; Sinnige HA; Nooijen P; Schipper DL; Nissen LH
    World J Gastroenterol; 2016 Dec; 22(47):10465-10470. PubMed ID: 28058028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease.
    Peyrin-Biroulet L; Oussalah A; Williet N; Pillot C; Bresler L; Bigard MA
    Gut; 2011 Jul; 60(7):930-6. PubMed ID: 21228429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytomegalovirus primary infection in a patient with Crohn's disease treated with azathioprine and anti-TNF alpha].
    Ben Hriz F; Habbessi H; Maamouri N; Belkahla N; Ouerdiane S; Chouaib S; Ouerghi H; Chaabouni H; Ben Mami N
    Tunis Med; 2009 Aug; 87(8):545-6. PubMed ID: 20180364
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of chronic inflammatory bowel diseases. TNF-alpha blocker in Crohn disease: earlier use is rewarding].
    MMW Fortschr Med; 2008 Dec; 150(51-52):54-5. PubMed ID: 19156959
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppression in patients with Crohn's disease and neoplasia: an ongoing clinical dilemma.
    Dasari BV; McBrearty A; Gardiner K
    Dis Colon Rectum; 2012 Sep; 55(9):1008-11. PubMed ID: 22874610
    [No Abstract]   [Full Text] [Related]  

  • 9. Mucormycosis in a Crohn's disease patient treated with infliximab.
    Wall GC; Leman BI
    Digestion; 2009; 80(3):182-4. PubMed ID: 19776582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
    Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatosplenic T cell lymphoma in inflammatory bowel disease.
    Shale M; Kanfer E; Panaccione R; Ghosh S
    Gut; 2008 Dec; 57(12):1639-41. PubMed ID: 18667489
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bacillus cereus bacteremia in Crohn's disease with multiple ileal stricture on maintenance azathioprine therapy].
    Hizawa K; Nagata Y; Taniguchi M; Nakamori M; Matsumoto T; Iida M
    Nihon Shokakibyo Gakkai Zasshi; 2009 Jan; 106(1):56-60. PubMed ID: 19122422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmablastic lymphoma presenting as a paravertebral mass in a patient with Crohn's disease after immunosuppressive therapy.
    Redmond M; Quinn J; Murphy P; Patchett S; Leader M
    J Clin Pathol; 2007 Jan; 60(1):80-1. PubMed ID: 17213349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-TNF (infliximab) treatment in Crohn disease: safety profile].
    Carroccio A; Di Prima L; Pirrone G; Ambrosiano G; Noto D; Cefalù AB
    Recenti Prog Med; 2006 Feb; 97(2):108-12; quiz 122. PubMed ID: 16671277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re: Disappearance of Crohn's ulcers in the terminal ileum after thalidomide therapy. Can J Gastroenterol 2004; 18(2): 101-104.
    Cohen LB
    Can J Gastroenterol; 2004 Jun; 18(6):419; author reply 419. PubMed ID: 15230268
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple cutaneous malignancies arising in a patient with Crohn disease treated with concomitant azathioprine and antitumour necrosis factor-alpha.
    Fogo AJ; Hunt JB; Clement M
    Clin Exp Dermatol; 2010 Oct; 35(7):793-5. PubMed ID: 20345989
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease.
    Thayu M; Markowitz JE; Mamula P; Russo PA; Muinos WI; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):220-2. PubMed ID: 15699701
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hodgkin's lymphoma in a patient with Crohn's disease treated with azathioprine and antibodies anti tumor necrosis factor α].
    Sagüés M; Navarro JT; Ribera JM; Millá F
    Med Clin (Barc); 2012 Apr; 138(8):366-7. PubMed ID: 21752407
    [No Abstract]   [Full Text] [Related]  

  • 19. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.
    Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM
    Hepatogastroenterology; 2006; 53(69):399-404. PubMed ID: 16795981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful desensitization to 6-mercaptopurine in a patient with Crohn's disease.
    Mutinga M; Castells M; Horan R; Farraye FA
    Am J Gastroenterol; 2000 May; 95(5):1383-4. PubMed ID: 10811376
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.